<--- Back to Details
First PageDocument Content
Clinical medicine / Medicine / Health / Neuroendocrinology / Pancreatic cancer / Neuroendocrine tumor / Advanced Accelerator Applications / Pheochromocytoma / Paraganglioma / DOTA-TATE / Forward-looking statement / Endocrine oncology
Date: 2016-08-02 07:01:40
Clinical medicine
Medicine
Health
Neuroendocrinology
Pancreatic cancer
Neuroendocrine tumor
Advanced Accelerator Applications
Pheochromocytoma
Paraganglioma
DOTA-TATE
Forward-looking statement
Endocrine oncology

Add to Reading List

Source URL: www.adacap.com

Download Document from Source Website

File Size: 566,40 KB

Share Document on Facebook

Similar Documents

Clinical medicine / Medicine / Health / Neuroendocrinology / Pancreatic cancer / Neuroendocrine tumor / Advanced Accelerator Applications / Pheochromocytoma / Paraganglioma / DOTA-TATE / Forward-looking statement / Endocrine oncology

PDF Document

DocID: 1qqKS - View Document

PRESS RELEASE Advanced Accelerator Applications Announces FDA Approval of NETSPOTTM (Somakit-TATE), a Kit for the Preparation of Gallium Ga 68 Dotatate for Neuroendocrine Tumor Detection NETSPOT

DocID: 1opwO - View Document

Accelerator physics / Canadian Light Source / University of Saskatchewan / Synchrotron / Beamline / University of Alberta

FASTER SMARTER RICHER Sector Focus: Structural biology Advanced Applications Project: End-to-End Lightpaths at Synchrotrons

DocID: 1oniz - View Document

  M/F Director of Sales and Marketing, Spain (Barcelona) About us: Advanced Accelerator Applications (www.adacap.com) is a European Pharmaceutical Group founded in 2002 as a spin-off of the European Organization for Nu

DocID: 1kkXY - View Document

    COMMUNIQUE DE PRESSE Advanced Accelerator Applications réalise une levée de fonds de 41 millions d’euros Points clefs:

DocID: 1k602 - View Document